A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment
NCT ID: NCT00772733
Last Updated: 2011-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
936 participants
OBSERVATIONAL
2008-10-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognosis and Treatment of COPD in Primary Care-use of Biomarkers
NCT01698151
European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00722267
Danish Quality Assurance Project on Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD) in Outpatient Lung Clinics
NCT00268866
Biomarkers of Early Chronic Obstructive Pulmonary Disease (COPD) in Smokers - Longitudinal Study
NCT02076061
Factors Determining Quality of Life Related to Respiratory Status According to Gender of Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01007734
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having given informed consent
Exclusion Criteria
35 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca Pharmaceuticals
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Skov Jensen, MD
Role: STUDY_CHAIR
Region Hospital Viborg, DK
Tina Brandt Sorensen, MD
Role: STUDY_CHAIR
Region Hospital Horsens, DK
Ove Grann
Role: PRINCIPAL_INVESTIGATOR
Aalborg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Aarhus, Arhus, Denmark
Research Site
Bjerringbro, Viborg, Denmark
Research Site
Møldrup, Viborg, Denmark
Research Site
Skals, Viborg, Denmark
Research Site
Aalborg, , Denmark
Research Site
Klarup, , Denmark
Research Site
Skive, , Denmark
Research Site
Spøttrup, , Denmark
Research Site
Stoholm, , Denmark
Research Site
Viborg, , Denmark
Research Site
Ørum, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-RDK-DUM-2007/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.